https://doi.org/10.1016/s2468-1253(16)30181-9
C
Christophe Moreno
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
395
Papers
22.7K
Citations
71
h-index
172
i10-index
Christophe Moreno is an academic researcher from Tulane University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Hepatitis C virus research & Alcohol Consumption and Health Effects. The author has an h-index of 71, co-authored 336 publications.
ORCID: 0009-0001-5305-2483Papers by this author
worksGlobal prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
2016 · The Lancet. Gastroenterology & hepatology · 2,006 citations
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
2019 · The Lancet · 1,172 citations
https://doi.org/10.1016/s0140-6736(19)33041-7
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
2021 · New England Journal of Medicine · 655 citations
https://doi.org/10.1056/nejmoa2036205
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
2022 · The Lancet. Gastroenterology & hepatology · 627 citations
https://doi.org/10.1016/s2468-1253(21)00472-6
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis
2018 · Journal of Hepatology · 157 citations
https://doi.org/10.1016/j.jhep.2018.03.007
Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study
2022 · Research Portal (King's College London) · 120 citations
https://doi.org/10.1016/s2468-1253
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat